Dilara Bahceci, PhD

The future of #psychedelic research!

Thanks to @samuelbphd.bsky.social for the photo!

Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression: a pooled participant analysis of randomized controlled trials Background Racemic ketamine and its enantiomer, esketamine, have emerged as fast-acting antidepressant options for individuals with treatment-resistant depression (TRD). Yet, despite growing clinical ...

🧠💥 Our new preprint is out!

We pooled 5 RCTs on intranasal esketamine for treatment-resistant depression—and found clear sex-specific patterns in how patients respond.
Read it here: www.medrxiv.org/content/10.1...

#TRD #Esketamine #Neuropsychiatry #OpenScience #MentalHealth